People Briefs: Elekta, Zeltiq And Nonin Make Appointments; Gilfillan Goes To CHE Trinity Health
This article was originally published in The Gray Sheet
Executive Summary
Elekta appoints president and CEO. Former Conceptus CEO D. Keith Grossman joins Zeltiq board. Former Center for Medicare and Medicaid Innovation Director Richard Gilfillan will head CHE Trinity Health. More people news.
You may also be interested in...
Rick Gilfillan Leaving CMS Innovation Center By June 30
Gilfillan, who is the first director of CMS’ Center for Medicare and Medicaid Innovation, will leave CMS by the end of June after almost three years at the helm of the center established in 2010 to experiment with and help implement new health care delivery and payment models.
Bayer Buys Essure Contraceptive-Maker Conceptus For $1.1 Billion
The acquisition will add a popular nonsurgical, permanent birth control device to Bayer’s line of contraceptive pharmaceuticals and women’s health products.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.